PATIENT REPORTED OUTCOMES AMONG PATIENTS RECEIVING TREATMENT FROM THE PEGLOTICASE PHASE 3 CLINICAL TRIALS FOR UNCONTROLLED GOUT

被引：1
|
作者：
Sparks, J. [1 ]
Obermeyer, K. [2 ]
Lamoreaux, B. [3 ]
机构：
[1] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[2] Horizon Therapeut Plc, Biostat, Deerfield, IL USA
[3] Horizon Therapeut Plc, Med Affairs, Deerfield, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
QUALITY-OF-LIFE;
D O I：
10.1136/annrheumdis-2022-eular.1156
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1039
引用
收藏
页码：1643 / 1643
页数：1
相关论文
共 50 条
  • [41] Validity of patient-reported outcomes to describe the symptom experience of patients enrolled on phase I clinical trials.
    Sedhom, Ramy
    Ferrell, Betty R.
    Ruel, Nora
    Koczywas, Marianna
    Chung, Vincent
    Smith, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
    Dooley, M. A.
    Houssiau, F.
    Aranow, C.
    D'Cruz, D. P.
    Askanase, A.
    Roth, D. A.
    Zhong, Z. J.
    Cooper, S.
    Freimuth, W. W.
    Ginzler, E. M.
    LUPUS, 2013, 22 (01) : 63 - 72
  • [43] Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
    Baraf, Herbert S. B.
    Becker, Michael A.
    Gutierrez-Urena, Sergio R.
    Treadwell, Edward L.
    Vazquez-Mellado, Janitzia
    Rehrig, Claudia D.
    Ottery, Faith D.
    Sundy, John S.
    Yood, Robert A.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
  • [44] PROGRESSIVE CLINICAL BENEFIT IN CHRONIC REFRACTORY GOUT PATIENTS ACHIEVING A PERSISTENT URATE LOWERING EFFECT FROM PEGLOTICASE TREATMENT
    Khanna, P.
    Mandell, B.
    Fleischmann, R.
    Kay, J.
    Yeo, A.
    Lipsky, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1368 - 1368
  • [45] Efficacy and safety of intravenous (IV) pegloticase (PGL) in subjects with treatment failure gout (TFG): Phase 3 results from GOUT1 and GOUT2
    Sundy, J. S.
    Baraf, H. S.
    Becker, M. A.
    Edwards, N. L.
    Gutierrez-Urena, S. R.
    Treadwell, E. L.
    Vazquez-Mellado, J.
    Yood, R. A.
    Horowitz, Z.
    Huang, B.
    Maroli, A.
    Waltrip, R.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S400 - S401
  • [46] Hydroflex: Use of Patient Reported Outcomes in a Clinical Setting Among Patients with Hydrocephalus
    Astradsson, Arnar
    Sorensen, Nanna Toxvig
    Graversen, Anne Sofie
    Nemeiko, Ivona
    Bilgin-Freiert, Arzu
    Stephansen, Lene Vinding
    Einarsson, Halldor Bjarki
    Schougaard, Liv Marit Valen
    Juhler, Marianne
    Hansen, Torben Skovbo
    WORLD NEUROSURGERY, 2023, 169 : E67 - E72
  • [47] Dupilumab Improves Patient-Reported Outcomes In Uncontrolled Persistent Asthma: Results From A Phase 2b Clinical Trial
    Chanez, P.
    Corren, J.
    Castro, M.
    Fabbri, L.
    Joish, V. N.
    Evans, R. E.
    Graham, N. M. H.
    Mastey, V.
    Abbe, A.
    Taniou, C.
    Mahajan, S.
    Teper, A.
    Pirozzi, G.
    Eckert, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [48] Patient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care
    Narra, Lakshmi Rekha
    Verdini, Nicholas
    Lapen, Kaitlyn
    Nipp, Ryan
    Gillespie, Erin F.
    SEMINARS IN RADIATION ONCOLOGY, 2023, 33 (04) : 358 - 366
  • [49] ASSOCIATIONS BETWEEN PATIENT-REPORTED OUTCOMES, CLINICAL OUTCOMES, AND AGE IN LUNG CANCER PATIENTS RECEIVING IMMUNOTHERAPY
    Fleszar-Pavlovic, Sara E.
    Natori, Akina
    Moreno, Patricia I.
    Medina, Heidy N.
    Sookdeo, Vandana D.
    MacIntyre, Jessica
    Penedo, Frank J. J.
    ANNALS OF BEHAVIORAL MEDICINE, 2024, 58 : S270 - S270
  • [50] Patient-reported outcomes in HIV clinical trials evaluating antiretroviral treatment: a systematic review
    Akinosoglou, Karolina
    Antonopoulou, Stefania
    Katsarolis, Ioannis
    Gogos, Charalambos A.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2021, 33 (09): : 1118 - 1126
12345